Metrix COVID-19 Test
Commercial- Indications
- COVID-19
Company intelligence / Profile preview
Aptitude’s Metrix® platform delivers lab-quality molecular diagnostic results at the point of care or at home. The FDA has authorized its COVID‑19 test for over-the-counter use with saliva or swab samples. The company is developing a multiplex STI test and a flu/COVID multiplex panel. Clinical validation studies are ongoing in the US and Africa with support from major global health funders.
2 more assets in the full pipeline.
Request access →Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Aptitude Medical Systems.